John P. Longenecker Ph.D. is Director at Pacira Pharmaceuticals, Inc. (PCRX). They have made 6 open-market trades across 3 companies since 2008, most recently 2022-03-03.
CIK 0001288231
2 open-market purchases totalling $44K since 2016, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCRX | SELL | 2022-03-03 | 2022-03-07 | $71.74 | $1.0M | +4.1% | +12.0% | -14.0% |
| PCRX | SELL | 2021-03-01 | 2021-03-03 | $72.26 | $361K | +5.3% | +0.1% | -9.0% |
| PCRX | SELL | 2019-12-02 | 2019-12-04 | $46.13 | $60K | -1.2% | -3.2% | -10.1% |
| ALRN | BUY | 2018-08-10 | 2018-08-14 | $2.45 | $25K | -6.9% | +29.9% | -21.2% |
| PCRX | BUY | 2016-01-12 | 2016-01-14 | $66.55 | $20K | +0.7% | -5.4% | +1.8% |
| PCRX | SELL · 10b5-1 | 2015-03-12 | 2015-03-16 | $95.28 | $286K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2014-12-29 | 2014-12-30 | $93.32 | $93K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2014-09-29 | 2014-09-30 | $96.40 | $96K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2014-06-30 | 2014-07-02 | $91.60 | $92K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2014-03-28 | 2014-03-31 | $64.63 | $65K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2013-12-30 | 2014-01-02 | $55.55 | $139K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2013-09-30 | 2013-10-02 | $46.74 | $117K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2013-06-28 | 2013-07-02 | $28.09 | $56K | -18.1% | +0.8% | +0.8% |
| PCRX | SELL · 10b5-1 | 2013-03-28 | 2013-04-01 | $28.49 | $57K | -18.1% | +0.8% | +0.8% |
| FVRL | SELL | 2008-12-11 | 2008-12-15 | $0.02 | $3K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.